| 1. | longswin | |
| 2. | debgptl | |
| 3. | STOCKnLAW | |
| 4. | deathswrestler | |
| 5. | deadRinger |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | deathswrestler 06/27/2018 Announces that the European Commission has approved DZUVEO |
| 2. | deadRinger 10/02/2017 Cool off before the 12th then jump? |
| 3. | STOCKnLAW 10/02/2017 Demand AH continues. Only 7 trading days til FDA decision, or earlier?!. |
| 4. | longswin 04/16/2018 News out here - AcelRx Announces Completion of the Human Factors Study for DSUVIA and Confirms Plans to Resubmit NDA in Q2 2018 |
| 5. | deathswrestler 04/18/2018 Announces the publication of an analysis of the pharmacokinetic characteristics of sublingually administered… |
| 6. | STOCKnLAW 10/03/2017 Lots more to run |
| 7. | deadRinger 10/03/2017 Upcoming catalysts |
| 8. | longswin 04/11/2018 Announces publication of a report commissioned by AcelRx analyzing the economic burden associated with admin… |
| 9. | debgptl 03/12/2018 Reports Q4 net loss of $0.74 per share |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
AcelRx Pharmaceuticals, Inc.
- ACRX
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.